Company
Danaher Corporation
NYSE:DHR
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The company’s Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services that are used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines.
15 stories
IPO Roundup: Danaher's dental spin-off Envista shows its pearly whites in strong public debut
The Brea, California company offered 26.8 million shares at $28 per share, within its expected range of $21 to $24
IPO Roundup: Cloud-monitoring company Datadog chases $7 billion valuation this week
Dental supplies provider Envista is also looking to secure the biggest IPO of the week
PRE-MARKET MOVERS: Tesla revs up before the bell but Danaher goes into reverse
Also before the New York bell, Dell Technologies Inc and Constellation Brands Inc were in the frame.
Danaher expects 2018 net EPS to be above 2017 consensus, but sees adjusted EPS a touch lighter
The NYSE-listed firm said it expects its 2018 net EPS to rise to a range of US$3.50 to US$3.60, which is around 3% to 5% above the 2017 consensus of US$3.40
US shares hold onto light gains after Sept rate hike risk ebbs
Weak ISM data more or less writes off risk of September US rate hike
Wall Street closes lower as Brexit and weaker oil prices weigh
US stocks closed soft on Tuesday after Brexit headwinds and weaker oil prices made it impossible for prices to dig out of their hole
US stocks nurse losses as post-Brexit hurts oil prices
US stocks were bruised at midsession on Tuesday, after the UK’s Brexit vote once more haunted assets including sharply depressed oil prices
Dow Jones suffers triple-digit fall
Resource stocks were hit especially hard as US investors played catch-up following the 4 July market holiday
Dow Jones suffers triple-digit fall
Miners and oilers were especially hard hit, as stocks followed global markets lower
Wall Street trades in narrow range as investors assess data, yields
U.S. stocks traded in a narrow range today as corporate deal activity was offset by concern a fixed-income selloff may resume, and investors considered a downbeat retail sales report. The S&P 500 (INDEXSP:.INX) inched down less than 0.1
U.S. stock-index futures pare early gains after retail sales, import-price index disappoint
U.S. stock-index futures trimmed early gains after a slate of weaker-than-expected economic data. Futures for the Dow Jones Industrial Average climbed 0.1 percent, while those for the S&P 500 index gained 0.2 percent. Danaher (NYSE:DHR)